Clinical trials
Polyneuropathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 6 |
| Terminated | 3 |
| Withdrawn | 3 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 4 |
| Pfizer | 3 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Abbott Medical Devices | 1 |
| AstraZeneca | 1 |
| Austin Neuromuscular Center | 1 |
| Baxalta now part of Shire | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Eastern Virginia Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyneuropathies | 30 |
| Amyloidosis | 12 |
| Amyloid Neuropathies, Familial | 8 |
| Peripheral Nervous System Diseases | 7 |
| Amyloidosis, Familial | 5 |
| Pain | 5 |
| Alzheimer Disease | 4 |
| Amyloid Neuropathies | 3 |
| Diabetic Neuropathies | 3 |
| Neuromuscular Diseases | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.